40 results
DEFA14A
ZOM
Zomedica Corp
6 Feb 24
Additional proxy soliciting materials
5:14pm
capital structure, enhance the appeal of our common shares to the financial community, remove economic disincentives related to purchasing low-priced
DEFA14A
ZOM
Zomedica Corp
24 Jan 24
Additional proxy soliciting materials
1:38pm
investors who track these indices.
A higher per share price could increase interest from the equity research analyst community, potentially expanding
DEFA14A
ZOM
Zomedica Corp
17 Jan 24
Additional proxy soliciting materials
4:01pm
attention from the equity research analyst community, potentially expanding coverage of the company. This expanded coverage could, in turn, introduce
8-K
EX-99.1
tssua4l
9 May 23
Other Events
8:57am
8-K
EX-99.1
06j0wgzuohwv emk
24 Aug 22
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
4:57pm
8-K
EX-99.1
5e0hn2
20 Jul 22
Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health
4:38pm
8-K
EX-99.1
67i6wjr6vzne6htze
16 Mar 21
Zomedica Announces First Commercial Sale of Its Truforma® Platform
6:15am
8-K
EX-99.1
1f8s8ekil mlr2vt
16 Nov 20
Certain assays under development are believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine
4:01pm
424B3
gqt2i2
26 Oct 20
Prospectus supplement
9:21am